Screener
Mirum Pharmaceuticals, Inc. MIRM Finite Lived Intangible Assets - Gross
Finite Lived Intangible Assets - Gross at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.
The source filing: Mirum Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759425-26-000045
| Line item | Gross Carrying Value | Accumulated Amortization | Net Carrying Amount | Weighted-Average Remaining Amortization Period (Years) |
|---|---|---|---|---|
| Commercial milestones | $94,000 | $(15,527) | $78,473 | 11.1 |
| Developed technology | 226,620 | (57,759) | 168,861 | 9.3 |
| Assembled workforce | 970 | (916) | 54 | 0.2 |
| Total intangible assets | $321,590 | $(74,202) | $247,388 | 9.8 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Mirum Pharmaceuticals, Inc.'s finite lived intangible assets - gross?
- Mirum Pharmaceuticals, Inc. (MIRM) reported finite lived intangible assets - gross of $321.59M in Q2 2026.
- How has Mirum Pharmaceuticals, Inc.'s finite lived intangible assets - gross changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s finite lived intangible assets - gross increased by 12.2% year-over-year, from $286.59M to $321.59M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s finite lived intangible assets - gross?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s finite lived intangible assets - gross has grown at a 9.8% compound annual growth rate (CAGR), from $266.59M to $321.59M.
- What does finite lived intangible assets - gross mean?
- This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.
Ask your AI about Mirum Pharmaceuticals, Inc.'s finite lived intangible assets - gross.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude